First Time Loading...

Mediclin AG
XETRA:MED

Watchlist Manager
Mediclin AG Logo
Mediclin AG
XETRA:MED
Watchlist
Price: 2.9 EUR 1.4% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. [ Read More ]

The intrinsic value of one MED stock under the Base Case scenario is 18.52 EUR. Compared to the current market price of 2.9 EUR, Mediclin AG is Undervalued by 84%.

Key Points:
MED Intrinsic Value
Base Case
18.52 EUR
Undervaluation 84%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Mediclin AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MED stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Mediclin AG

Provide an overview of the primary business activities
of Mediclin AG.

What unique competitive advantages
does Mediclin AG hold over its rivals?

What risks and challenges
does Mediclin AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mediclin AG.

Provide P/S
for Mediclin AG.

Provide P/E
for Mediclin AG.

Provide P/OCF
for Mediclin AG.

Provide P/FCFE
for Mediclin AG.

Provide P/B
for Mediclin AG.

Provide EV/S
for Mediclin AG.

Provide EV/GP
for Mediclin AG.

Provide EV/EBITDA
for Mediclin AG.

Provide EV/EBIT
for Mediclin AG.

Provide EV/OCF
for Mediclin AG.

Provide EV/FCFF
for Mediclin AG.

Provide EV/IC
for Mediclin AG.

Show me price targets
for Mediclin AG made by professional analysts.

What are the Revenue projections
for Mediclin AG?

How accurate were the past Revenue estimates
for Mediclin AG?

What are the Net Income projections
for Mediclin AG?

How accurate were the past Net Income estimates
for Mediclin AG?

What are the EPS projections
for Mediclin AG?

How accurate were the past EPS estimates
for Mediclin AG?

What are the EBIT projections
for Mediclin AG?

How accurate were the past EBIT estimates
for Mediclin AG?

Compare the revenue forecasts
for Mediclin AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Mediclin AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mediclin AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mediclin AG compared to its peers.

Compare the P/E ratios
of Mediclin AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Mediclin AG with its peers.

Analyze the financial leverage
of Mediclin AG compared to its main competitors.

Show all profitability ratios
for Mediclin AG.

Provide ROE
for Mediclin AG.

Provide ROA
for Mediclin AG.

Provide ROIC
for Mediclin AG.

Provide ROCE
for Mediclin AG.

Provide Gross Margin
for Mediclin AG.

Provide Operating Margin
for Mediclin AG.

Provide Net Margin
for Mediclin AG.

Provide FCF Margin
for Mediclin AG.

Show all solvency ratios
for Mediclin AG.

Provide D/E Ratio
for Mediclin AG.

Provide D/A Ratio
for Mediclin AG.

Provide Interest Coverage Ratio
for Mediclin AG.

Provide Altman Z-Score Ratio
for Mediclin AG.

Provide Quick Ratio
for Mediclin AG.

Provide Current Ratio
for Mediclin AG.

Provide Cash Ratio
for Mediclin AG.

What is the historical Revenue growth
over the last 5 years for Mediclin AG?

What is the historical Net Income growth
over the last 5 years for Mediclin AG?

What is the current Free Cash Flow
of Mediclin AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mediclin AG.

Financials

Balance Sheet Decomposition
Mediclin AG

Current Assets 299.8m
Cash & Short-Term Investments 174.4m
Receivables 94.3m
Other Current Assets 31.2m
Non-Current Assets 580.7m
Long-Term Investments 66.9k
PP&E 514.4m
Intangibles 22.8m
Other Non-Current Assets 43.4m
Current Liabilities 171.2m
Accounts Payable 12.6m
Other Current Liabilities 158.6m
Non-Current Liabilities 513.3m
Long-Term Debt 428.9m
Other Non-Current Liabilities 84.5m
Efficiency

Earnings Waterfall
Mediclin AG

Revenue
766.7m EUR
Cost of Revenue
-137.4m EUR
Gross Profit
629.4m EUR
Operating Expenses
-610.6m EUR
Operating Income
18.7m EUR
Other Expenses
-29.5m EUR
Net Income
-10.8m EUR

Free Cash Flow Analysis
Mediclin AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

MED Profitability Score
Profitability Due Diligence

Mediclin AG's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
ROIC is Increasing
Positive 3-Years Revenue Growth
48/100
Profitability
Score

Mediclin AG's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

MED Solvency Score
Solvency Due Diligence

Mediclin AG's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
High D/E
32/100
Solvency
Score

Mediclin AG's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MED Price Targets Summary
Mediclin AG

Wall Street analysts forecast MED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MED is 4.54 EUR with a low forecast of 3.84 EUR and a high forecast of 5.36 EUR.

Lowest
Price Target
3.84 EUR
32% Upside
Average
Price Target
4.54 EUR
57% Upside
Highest
Price Target
5.36 EUR
85% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

MED Price
Mediclin AG

1M 1M
+24%
6M 6M
+9%
1Y 1Y
-2%
3Y 3Y
-35%
5Y 5Y
-46%
10Y 10Y
-31%
Annual Price Range
2.9
52w Low
2.3
52w High
3.1
Price Metrics
Average Annual Return -10.67%
Standard Deviation of Annual Returns 9.34%
Max Drawdown -60%
Shares Statistics
Market Capitalization 137.8m EUR
Shares Outstanding 47 500 000
Percentage of Shares Shorted
N/A

MED Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Mediclin AG Logo
Mediclin AG

Country

Germany

Industry

Health Care

Market Cap

137.8m EUR

Dividend Yield

0%

Description

MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. The company is headquartered in Offenburg, Baden-Wuerttemberg and currently employs 7,115 full-time employees. The company went IPO on 2000-12-04. The firm operates more than 50 facilities across Germany. Its portfolio comprises hospitals (acute care), rehabilitation clinics, care homes and medical care centers. The Group also offers a range of specialist medical services, such as neurosurgery, as well as specialist facilities, including heart centers, early neurological rehabilitation facilities and a specialist orthopedic hospital. In addition to that, it offers specialist services in the area of neuroradiology, as well as in psychological sciences (psychosomatics and psychiatry), orthopedics, in the areas of Ear, nose, and throat (ENT), oncology (radiotherapy) and inner medicine (including cardiology, pneumology and endocrinology).

Contact

BADEN-WUERTTEMBERG
Offenburg
Okenstr. 27
+497814880.0
https://www.mediclin.de/

IPO

2000-12-04

Employees

7 115

Officers

Chairman of Management Board & CEO
Dr. Joachim Ramming
CFO & Member of the Management Board
Mr. Tino Fritz
COO & Member of Management Board
Mr. Thomas Piefke
Head of Group Accounting
Mr. Mario Waidele
Head of Investor Relations and Sustainability
Ender Gulcan
Head of Law
Ms. Katja Kiesewetter
Show More
Head of Purchasing & Medical Technology
Mr. Jörg Störmer
Head of Payroll & Application Management
Ms. Carin Emminghaus
Head of Quality Medicine & Head of Internal Auditing
Dr. Ralf BĂĽrgy
Head of Finance & Accounting
Mr. Frank Heuberger
Show Less

See Also

Discover More
What is the Intrinsic Value of one MED stock?

The intrinsic value of one MED stock under the Base Case scenario is 18.52 EUR.

Is MED stock undervalued or overvalued?

Compared to the current market price of 2.9 EUR, Mediclin AG is Undervalued by 84%.